81 results
8-K
EX-10.1
FATE
Fate Therapeutics Inc
20 Mar 24
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
5:32pm
to the Buyers obligated to purchase at least a majority of the Warrant Shares; and
(d) The Company shall have delivered to the Buyers an officer’s … to the Buyers obligated to purchase at least a majority of the Warrant Shares.
8. CERTAIN DEFINED TERMS.
For purposes of this Agreement, the following terms
424B5
FATE
Fate Therapeutics Inc
20 Mar 24
Prospectus supplement for primary offering
5:30pm
of a majority in voting power of the outstanding shares of our capital stock irrespective of the provisions of Section 242(b)(2) of the DGCL.
As of September 30 … be filled by the affirmative vote of a majority of our directors then in office even if less than a quorum.
No Written Consent of Stockholders. Our
S-8
EX-99.1
kuxjac1g o4ppcx
9 Jun 22
Registration of securities for employees
4:40pm
S-3ASR
jn9dm00qh3np 420
4 Nov 21
Automatic shelf registration
4:56pm